Drug intelligence / Profile preview

Leigongtengduogan + Yishen Juanbi Wan

Development stage
Preclinical
Lead developer
藥捷安康
Modality
Small Molecules
Administration
Oral
01

Overview

Leigongtengduogan + Yishen Juanbi Wan is a combination of two traditional Chinese medicine (TCM) products used primarily for the treatment of rheumatoid arthritis (RA). - **Leigongtengduogan** refers to Tripterygium glycosides, extracted from the herb Tripterygium wilfordii Hook F ("Thunder God Vine"), known for its immunosuppressive and anti-inflammatory properties. - **Yishen Juanbi Wan** is a classic TCM herbal compound formulation widely used in China to treat RA with kidney deficiency syndrome. It has demonstrated efficacy in reducing joint inflammation, inhibiting osteoclast differentiation, and protecting against bone destruction in both clinical and preclinical studies[1][2][4][5]. Mechanistically, it modulates immune responses by regulating T cell phenotypes (Th17/Treg balance), cytokine levels (IL-6, IL-17A, IL-10, TGF-beta1), and signaling pathways such as JAK2/STAT3[5]. This combination therapy is under investigation for its precise indications in RA management[2], aiming to leverage both the potent immunomodulatory effects of Tripterygium glycosides and the multi-targeted actions of Yishen Juanbi Wan.

Other names
Leigongtengduogan Pian + Yishen Juanbi Wan雷公藤多苷片+益肾蠲痹丸
02

Targets

STAT3 (Signal Transducer and Activator of Transcription 3)NFATC1JAK2 (Janus kinase 2)

Beyond the preview

Go deeper on Leigongtengduogan + Yishen Juanbi Wan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Leigongtengduogan + Yishen Juanbi Wan.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call